Y-mAbs Therapeutics Misses Expectations in Latest Earnings Release
Monday, 12 August 2024, 10:43
Y-mAbs Therapeutics Earnings Report Overview
Y-mAbs Therapeutics has released its latest earnings report, which reveals some disappointing figures for investors. The company's GAAP EPS was reported at -0.21, which is lower than the market expectation by 0.06.
Revenue Analysis
Additionally, Y-mAbs achieved a revenue of 22.8 million, falling short of the analysts' forecast by 0.22 million.
Conclusion
The results indicate challenges for the company as it strives to meet market expectations. Investors should keep an eye on Y-mAbs’ operations in the coming quarters.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.